Goldman Sachs @GoldmanSachs

CEO of Alnylam Pharmaceuticals Dr. Yvonne Greenstreet spoke with Jerry Lee, head of biopharmaceutical banking in the Global Healthcare Group in Global Banking & Markets, about the potential for RNA interference — what she believes will be a “generational technology.”

Watch on